Study of Vitamin D and Omega-3 Supplementation for Preventing Diabetes

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 22220 participants.

Also called NCT01633177

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 22,220 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01633177
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01633177. Randomized; triple masking; primary purpose prevention. Start 2011-11 (actual); primary completion 2024-05-30 (actual). Results posted on 2026-04-03.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Study of Vitamin D and Omega-3 Supplementation for Preventing Diabetes
Intervention (Dietary supplement)
Vitamin D3
Intervention (Drug)
Omega-3 fatty acid (fish oil)
Intervention (Dietary supplement)
Vitamin D3 placebo
Intervention (Drug)
Fish oil placebo
Lead sponsor
Brigham and Women's Hospital (class: other)
Collaborator
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (class: US National Institutes of Health)

Record details

Record id
cardio:ct-nct01633177
Content hash
cfb234f6c5652823c924c22aca3d6565e6ccc8dd391ceae7afb4e5200eb36650